2024

From seven to 435 workers in six years: the miracle of the virus cure factory
11/04/2024

An advanced therapies company against lethal diseases, Viralgen, has propelled San Sebastian to become the city with the highest R&D weight…

Read More
Multiverse raises $27M for quantum software targeting LLM leviathans
13/03/2024

We’re still years away from seeing physical quantum computers break into the market with any scale and reliability, but don’t give…

Read More
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIaArthemiRTM Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)
28/02/2024

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, announced that the U.S….

Read More
Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial in Patients with Relapsed/Refractory B-Cell Malignancies
22/02/2024

Aleta Biotherapeutics (Aleta), a clinical stage, immuno-oncology company with a CAR T-Cell Engager (CTE) platform that enables cell cancer therapies to…

Read More
Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158
16/02/2024

Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces that the first patient…

Read More